A Russian ballistic missile attack on Kyiv has killed at least three people and injured 20 others, with 14 hospitalised. The strike damaged residential buildings,
Moderna and Merck have reported promising results for their personalised mRNA cancer vaccine, Intismeran, which reduced melanoma recurrence and spread in late-stage trials. The interim